Cyprio

Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver model for different applications from drug-drug interaction screening, chronic toxicity and metabolism of low clearance compounds to disease modelling. Now Cyprio is developing additional products to definitively change liver cell culture biology approaches towards more complex and more relevant, yet more robust, easier to handle and HTS compatible 3D cellular models.